A Role for Noncoding Variation in Schizophrenia

Cell Reports

Volumn 9, Issue 4, 2014, Pages 1417-1429

  Roussos, Panos ^a,b   Mitchell, Amanda C ^a   Voloudakis, Georgios ^a   Fullard, John F ^a   Pothula, Venu M ^a   Tsang, Jonathan ^a   Stahl, Eli A ^a   Georgakopoulos, Anastasios ^a   Ruderfer, Douglas M ^a   Charney, Alexander ^a   Okada, Yukinori ^c,d   Siminovitch, Katherine A ^e,f,g   Worthington, Jane ^h,i   Padyukov, Leonid ^j   Klareskog, Lars ^j   Gregersen, Peter K ^k   Plenge, Robert M ^l,m   Raychaudhuri, Soumya ^l,m,n   Fromer, Menachem ^a   Purcell, Shaun M ^a   Brennand, Kristen J ^a   Robakis, Nikolaos K ^a   Schadt, Eric E ^a   Akbarian, Schahram ^a   Sklar, Pamela ^a   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d RIKEN Center for Integrative Medical Sciences   (Japan)

^e MOUNT SINAI HOSPITAL   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

^j KAROLINSKA INSTITUTE   (Sweden)

^k FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^l HARVARD MEDICAL SCHOOL   (United States)

^m BROAD INSTITUTE OF MIT AND HARVARD   (United States)

ⁿ MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL L TYPE; CACNA1C PROTEIN, HUMAN; PROTEIN BINDING; SPACER DNA;

ARTICLE; CACNA1C GENE; CONTROLLED STUDY; ENHANCER REGION; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MOLECULAR GENETICS; NERVE CELL; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PREFRONTAL CORTEX; PROMOTER REGION; QUANTITATIVE TRAIT LOCUS; REGULATORY SEQUENCE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; ANTIBODY SPECIFICITY; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; RHEUMATOID ARTHRITIS; RISK FACTOR;

ARTHRITIS, RHEUMATOID; CALCIUM CHANNELS, L-TYPE; DATABASES, GENETIC; DNA, INTERGENIC; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MOLECULAR SEQUENCE ANNOTATION; ORGAN SPECIFICITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RISK FACTORS; SCHIZOPHRENIA;

EID: 84912125156     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.10.015     Document Type: Article

References (58)

1. Andersson R., Gebhard C., Miguel-Escalada I., Hoof I., Bornholdt J., Boyd M., Chen Y., Zhao X., Schmidl C., Suzuki T., et al. An atlas of active enhancers across human cell types and tissues. Nature 2014, 507:455-461. FANTOM Consortium.
2. Bichet D., Cornet V., Geib S., Carlier E., Volsen S., Hoshi T., Mori Y., De Waard M. The I-II loop of the Ca2+ channel alpha1 subunit contains an endoplasmic reticulum retention signal antagonized by the beta subunit. Neuron 2000, 25:177-190.
3. Bigos K.L., Mattay V.S., Callicott J.H., Straub R.E., Vakkalanka R., Kolachana B., Hyde T.M., Lipska B.K., Kleinman J.E., Weinberger D.R. Genetic variation in CACNA1C affects brain circuitries related to mental illness. Arch. Gen. Psychiatry 2010, 67:939-945.
4. Brennand K.J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., Li Y., Mu Y., Chen G., Yu D., et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473:221-225.
5. Cheung I., Shulha H.P., Jiang Y., Matevossian A., Wang J., Weng Z., Akbarian S. Developmental regulation and individual differences of neuronal H3K4me3 epigenomes in the prefrontal cortex. Proc. Natl. Acad. Sci. USA 2010, 107:8824-8829.
6. Colantuoni C., Lipska B.K., Ye T., Hyde T.M., Tao R., Leek J.T., Colantuoni E.A., Elkahloun A.G., Herman M.M., Weinberger D.R., Kleinman J.E. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011, 478:519-523.
7. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381:1371-1379. Cross-Disorder Group of the Psychiatric Genomics Consortium.
8. Degner J.F., Pai A.A., Pique-Regi R., Veyrieras J.B., Gaffney D.J., Pickrell J.K., De Leon S., Michelini K., Lewellen N., Crawford G.E., et al. DNase I sensitivity QTLs are a major determinant of human expression variation. Nature 2012, 482:390-394.
9. Dimas A.S., Deutsch S., Stranger B.E., Montgomery S.B., Borel C., Attar-Cohen H., Ingle C., Beazley C., Gutierrez Arcelus M., Sekowska M., et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 2009, 325:1246-1250.
10. Erk S., Meyer-Lindenberg A., Schnell K., Opitz von Boberfeld C., Esslinger C., Kirsch P., Grimm O., Arnold C., Haddad L., Witt S.H., et al. Brain function in carriers of a genome-wide supported bipolar disorder variant. Arch. Gen. Psychiatry 2010, 67:803-811.
11. Fairfax B.P., Makino S., Radhakrishnan J., Plant K., Leslie S., Dilthey A., Ellis P., Langford C., Vannberg F.O., Knight J.C. Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat. Genet. 2012, 44:502-510.
12. Fanucchi S., Shibayama Y., Burd S., Weinberg M.S., Mhlanga M.M. Chromosomal contact permits transcription between coregulated genes. Cell 2013, 155:606-620.
13. Ferreira M.A., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., Fan J., Kirov G., Perlis R.H., Green E.K., et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat. Genet. 2008, 40:1056-1058. Wellcome Trust Case Control Consortium.
14. Fromer M., Pocklington A.J., Kavanagh D.H., Williams H.J., Dwyer S., Gormley P., Georgieva L., Rees E., Palta P., Ruderfer D.M., et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014, 506:179-184.
15. Gershon E.S., Grennan K., Busnello J., Badner J.A., Ovsiew F., Memon S., Alliey-Rodriguez N., Cooper J., Romanos B., Liu C. A rare mutation of CACNA1C in a patient with bipolar disorder, and decreased gene expression associated with a bipolar-associated common SNP of CACNA1C in brain. Mol. Psychiatry 2014, 19:890-894.
16. Gibbs J.R., van der Brug M.P., Hernandez D.G., Traynor B.J., Nalls M.A., Lai S.L., Arepalli S., Dillman A., Rafferty I.P., Troncoso J., et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 2010, 6:e1000952.
17. Grundberg E., Small K.S., Hedman A.K., Nica A.C., Buil A., Keildson S., Bell J.T., Yang T.P., Meduri E., Barrett A., et al. Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat. Genet. 2012, 44:1084-1089. Multiple Tissue Human Expression Resource (MuTHER) Consortium.
18. Harismendy O., Notani D., Song X., Rahim N.G., Tanasa B., Heintzman N., Ren B., Fu X.D., Topol E.J., Rosenfeld M.G., Frazer K.A. 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response. Nature 2011, 470:264-268.
19. Heintzman N.D., Hon G.C., Hawkins R.D., Kheradpour P., Stark A., Harp L.F., Ye Z., Lee L.K., Stuart R.K., Ching C.W., et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009, 459:108-112.
20. Herold M., Bartkuhn M., Renkawitz R. CTCF: insights into insulator function during development. Development 2012, 139:1045-1057.
21. Hori H., Yamamoto N., Fujii T., Teraishi T., Sasayama D., Matsuo J., Kawamoto Y., Kinoshita Y., Ota M., Hattori K., et al. Effects of the CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy individuals. Sci. Rep. 2012, 2:634.
22. Innocenti F., Cooper G.M., Stanaway I.B., Gamazon E.R., Smith J.D., Mirkov S., Ramirez J., Liu W., Lin Y.S., Moloney C., et al. Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissue. PLoS Genet. 2011, 7:e1002078.
23. Kagey M.H., Newman J.J., Bilodeau S., Zhan Y., Orlando D.A., van Berkum N.L., Ebmeier C.C., Goossens J., Rahl P.B., Levine S.S., et al. Mediator and cohesin connect gene expression and chromatin architecture. Nature 2010, 467:430-435.
24. Lee M.T., Chen C.H., Lee C.S., Chen C.C., Chong M.Y., Ouyang W.C., Chiu N.Y., Chuo L.J., Chen C.Y., Tan H.K., et al. Genome-wide association study of bipolar I disorder in the Han Chinese population. Mol. Psychiatry 2011, 16:548-556.
25. Lister R., Mukamel E.A., Nery J.R., Urich M., Puddifoot C.A., Johnson N.D., Lucero J., Huang Y., Dwork A.J., Schultz M.D., et al. Global epigenomic reconfiguration during mammalian brain development. Science 2013, 341:1237905.
26. Maurano M.T., Humbert R., Rynes E., Thurman R.E., Haugen E., Wang H., Reynolds A.P., Sandstrom R., Qu H., Brody J., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337:1190-1195.
27. Mitchell A.C., Bharadwaj R., Whittle C., Krueger W., Mirnics K., Hurd Y., Rasmussen T., Akbarian S. The genome in three dimensions: a new frontier in human brain research. Biol. Psychiatry 2014, 75:961-969.
28. Musunuru K., Strong A., Frank-Kamenetsky M., Lee N.E., Ahfeldt T., Sachs K.V., Li X., Li H., Kuperwasser N., Ruda V.M., et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 2010, 466:714-719.
29. Nica A.C., Montgomery S.B., Dimas A.S., Stranger B.E., Beazley C., Barroso I., Dermitzakis E.T. Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associations. PLoS Genet. 2010, 6:e1000895.
30. Nica A.C., Parts L., Glass D., Nisbet J., Barrett A., Sekowska M., Travers M., Potter S., Grundberg E., Small K., et al. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet. 2011, 7:e1002003. MuTHER Consortium.
31. Nicolae D.L., Gamazon E., Zhang W., Duan S., Dolan M.E., Cox N.J. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 2010, 6:e1000888.
32. Obermair G.J., Szabo Z., Bourinet E., Flucher B.E. Differential targeting of the L-type Ca2+ channel alpha 1C (CaV1.2) to synaptic and extrasynaptic compartments in hippocampal neurons. Eur. J. Neurosci. 2004, 19:2109-2122.
33. Okada Y., Wu D., Trynka G., Raj T., Terao C., Ikari K., Kochi Y., Ohmura K., Suzuki A., Yoshida S., et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014, 506:376-381. RACI consortium, GARNET consortiumGARNET consortium.
34. Paulus F.M., Bedenbender J., Krach S., Pyka M., Krug A., Sommer J., Mette M., Nöthen M.M., Witt S.H., Rietschel M., et al. Association of rs1006737 in CACNA1C with alterations in prefrontal activation and fronto-hippocampal connectivity. Hum. Brain Mapp. 2014, 35:1190-1200.
35. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat. Genet. 2011, 43:977-983. Psychiatric GWAS Consortium Bipolar Disorder Working Group.
36. Purcell S.M., Moran J.L., Fromer M., Ruderfer D., Solovieff N., Roussos P., O'Dushlaine C., Chambert K., Bergen S.E., Kähler A., et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014, 506:185-190.
37. Radua J., Surguladze S.A., Marshall N., Walshe M., Bramon E., Collier D.A., Prata D.P., Murray R.M., McDonald C. The impact of CACNA1C allelic variation on effective connectivity during emotional processing in bipolar disorder. Mol. Psychiatry 2013, 18:526-527.
38. Richards A.L., Jones L., Moskvina V., Kirov G., Gejman P.V., Levinson D.F., Sanders A.R., Purcell S., Visscher P.M., Craddock N., et al. Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain. Mol. Psychiatry 2012, 17:193-201. Molecular Genetics of Schizophrenia Collaboration (MGS), International Schizophrenia Consortium (ISC)International Schizophrenia Consortium (ISC).
39. Ripke S., O'Dushlaine C., Chambert K., Moran J.L., Kähler A.K., Akterin S., Bergen S.E., Collins A.L., Crowley J.J., Fromer M., et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 2013, 45:1150-1159. Multicenter Genetic Studies of Schizophrenia Consortium, Psychosis Endophenotypes International ConsortiumPsychosis Endophenotypes International Consortium, Wellcome Trust Case Control Consortium 2Wellcome Trust Case Control Consortium 2.
40. Rosenberg S.S., Spitzer N.C. Calcium signaling in neuronal development. Cold Spring Harb. Perspect. Biol. 2011, 3:a004259.
41. Roussos P., Giakoumaki S.G., Georgakopoulos A., Robakis N.K., Bitsios P. The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males. Bipolar Disord. 2011, 13:250-259.
42. Roussos P., Bitsios P., Giakoumaki S.G., McClure M.M., Hazlett E.A., New A.S., Siever L.J. CACNA1C as a risk factor for schizotypal personality disorder and schizotypy in healthy individuals. Psychiatry Res. 2013, 206:122-123.
43. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511:421-427. Schizophrenia Working Group of the Psychiatric Genomics Consortium.
44. Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 2012, 9:671-675.
45. Schork A.J., Thompson W.K., Pham P., Torkamani A., Roddey J.C., Sullivan P.F., Kelsoe J.R., O'Donovan M.C., Furberg H., Schork N.J., et al. All SNPs are not created equal: genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs. PLoS Genet. 2013, 9:e1003449. Tobacco and Genetics Consortium, Bipolar Disorder Psychiatric Genomics ConsortiumBipolar Disorder Psychiatric Genomics Consortium, Schizophrenia Psychiatric Genomics ConsortiumSchizophrenia Psychiatric Genomics Consortium.
46. Shulha H.P., Cheung I., Whittle C., Wang J., Virgil D., Lin C.L., Guo Y., Lessard A., Akbarian S., Weng Z. Epigenetic signatures of autism: trimethylated H3K4 landscapes in prefrontal neurons. Arch. Gen. Psychiatry 2012, 69:314-324.
47. Shulha H.P., Cheung I., Guo Y., Akbarian S., Weng Z. Coordinated cell type-specific epigenetic remodeling in prefrontal cortex begins before birth and continues into early adulthood. PLoS Genet. 2013, 9:e1003433.
48. Sklar P., Smoller J.W., Fan J., Ferreira M.A., Perlis R.H., Chambert K., Nimgaonkar V.L., McQueen M.B., Faraone S.V., Kirby A., et al. Whole-genome association study of bipolar disorder. Mol. Psychiatry 2008, 13:558-569.
49. Stahl E.A., Raychaudhuri S., Remmers E.F., Xie G., Eyre S., Thomson B.P., Li Y., Kurreeman F.A., Zhernakova A., Hinks A., et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 2010, 42:508-514. BIRAC Consortium, YEAR ConsortiumYEAR Consortium.
50. Tesli M., Skatun K.C., Ousdal O.T., Brown A.A., Thoresen C., Agartz I., Melle I., Djurovic S., Jensen J., Andreassen O.A. CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls. PLoS ONE 2013, 8:e56970.
51. Trynka G., Sandor C., Han B., Xu H., Stranger B.E., Liu X.S., Raychaudhuri S. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 2013, 45:124-130.
52. Visel A., Taher L., Girgis H., May D., Golonzhka O., Hoch R.V., McKinsey G.L., Pattabiraman K., Silberberg S.N., Blow M.J., et al. A high-resolution enhancer atlas of the developing telencephalon. Cell 2013, 152:895-908.
53. Wenger A.M., Clarke S.L., Notwell J.H., Chung T., Tuteja G., Guturu H., Schaar B.T., Bejerano G. The enhancer landscape during early neocortical development reveals patterns of dense regulation and co-option. PLoS Genet. 2013, 9:e1003728.
54. Westra H.J., Peters M.J., Esko T., Yaghootkar H., Schurmann C., Kettunen J., Christiansen M.W., Fairfax B.P., Schramm K., Powell J.E., et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 2013, 45:1238-1243.
55. Xia K., Shabalin A.A., Huang S., Madar V., Zhou Y.H., Wang W., Zou F., Sun W., Sullivan P.F., Wright F.A. seeQTL: a searchable database for human eQTLs. Bioinformatics 2012, 28:451-452.
56. Zhang B.G., Bodea L.G., Wang Z., McElwee J., Podtelezhnikov A.A., Zhang C., Xie T., Tran L., Dobrin R., Fluder E., et al. Tracing multi-system failure in Alzheimer disease to causal genes. Cell 2014, X, in press.
57. Zhong H., Beaulaurier J., Lum P.Y., Molony C., Yang X., Macneil D.J., Weingarth D.T., Zhang B., Greenawalt D., Dobrin R., et al. Liver and adipose expression associated SNPs are enriched for association to type 2 diabetes. PLoS Genet. 2010, 6:e1000932.
58. Zhu J., Adli M., Zou J.Y., Verstappen G., Coyne M., Zhang X., Durham T., Miri M., Deshpande V., De Jager P.L., et al. Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell 2013, 152:642-654.